Código QR (código de barras bidimensional)

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study

ABSTRACT Background In the era of novel agents, the clinical outcomes of induction treatment and the impact of the number of high‐risk cytogenetic abnormalities (HRA) in newly diagnosed multiple myeloma (NDMM) need to be explored. Objective Through this study, we aim to analyze the effectiveness of...

Fuld beskrivelse

Na minha lista:
Principais autores: Dong Liang, Xiaojin Li, Shenrui Bai, Qiaoli Wang, Min Zeng, Demei Feng, Bo Lu, Xiaoqing Li, Zhiqiang Sun, Jianyun Li, Huanhuan Zhou, Jialu Zhang, Xiaoqin Chen, Zhongjun Xia, Yang Liang, Hua Wang
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2024-10-01
Serier:Cancer Medicine
Fag:
1q21 gain/amplification
CD38
high risk cytogenetic abnormalities
newly diagnosed multiple myeloma
Online adgang:https://doi.org/10.1002/cam4.70270
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker